High Cholesterol

High cholesterol - everybody talks about it, 37 million American adults have high blood cholesterol levels, and 105 million have cholesterol levels that are higher than desirable (hypercholesterolemia). It is a deadly killer with NO visible symptoms. Find out what you need to do about it NOW so you don't become one of its victims.



When the levels of cholesterol in your bloodstream become too high, your likelihood of developing fatty deposits called plaques in your blood vessels increases. Over time, these plaques start to block your arteries, which impedes blood flow and creates a condition called atherosclerosis. Narrowing of the arteries that supply your heart with blood (coronary artery disease) can stop your heart muscles from getting enough blood , causing an increased risk of a heart attack. Similarly, a decreased blood flow to your brain can cause a stroke. Less blood flowing to your lower limbs can result in exercise-related pain or even gangrene.

Fortunately there are steps you can take today to start reducing your cholesterol levels - find out what changes you can make to your lifestyle or diet that can help bring your cholesterol levels down and improve your health. It has been estimated that a 10 percent reduction in cholesterol levels throughout the U.S. population would bring the rate of heart disease down by 30 percent.

Cholesterol News From Medical News Today

Latest Cholesterol News From Medical News Today.

'Tredaptive'® (Nicotinic Acid/Laropiprant) Authorised In The European Union: New Lipid-Modifying Therapy To Treat LDL-C, HDL-C And Triglycerides

Merck Sharp & Dohme Limited (MSD) announced recently that 'Tredaptive' (nicotinic acid/laropiprant) 1000 mg/20 mg modified-release tablets, a new lipid-modifying therapy for patients with dyslipidaemia and primary hypercholesterolaemia, has been authorised for marketing in the 27 member countries of the European Union (EU) and Iceland and Norway.1 'Tredaptive' combines nicotinic acid (niacin) and laropiprant, a novel flushing pathway inhibitor.

Results From The SEAS (Simvastatin And Ezetimibe In Aortic Stenosis) Study

The SEAS (Simvastatin and Ezetimibe in Aortic Stenosis) study has investigated the effects of intensive cholesterol lowering with the combination of simvastatin (40 mg daily) and ezetimibe (10 mg daily) in patients with aortic stenosis. Aortic stenosis (which involves partial blockage of the aortic valve in the heart) is a relatively common disease among older people in Western populations. Left untreated, it can progress to death from heart failure or cardiac arrest.

Independent Analyses Of The SEAS, SHARP And IMPROVE-IT Studies Of Statin Ezetimibe

The University of Oxford Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) proposed that the hypothesis-generating results of the SEAS trial of ezetimibe should be tested by reviewing the combined cancer results from the SHARP and IMPROVE-IT trials of ezetimibe, and reporting on the overall findings to the relevant regulatory authorities, independently of the drug manufacturers.

VAP Cholesterol Test Helps Reveal Association Between Adiponectin Levels And Atherosclerosis

Using the VAP Cholesterol Test from Atherotech, researchers have identified a link between adiponectin and heart disease progression. The information could help physicians trying to pinpoint the most effective cholesterol and heart disease risk-lowering treatments in at-risk patients.

Mitochondrial Cholesterol Makes Response To Chemotherapy Difficult In Hepatic Cancer

Cancer is a disease characterized by important metabolic alterations. Not only do these adaptative changes give higher proliferative capacity to cancer cells, but they also contribute to higher resistance to chemotherapeutic agents. The research group led by Dr.

Potential Health Risk Posed By 'Healthy' Sterols

Plant sterols have been touted as an effective way to lower cholesterol and reduce the risk of heart disease. However, a research study in the July JLR has uncovered that these compounds do have their own risks, as they can accumulate in heart valves and lead to stenosis. Aortic valve stenosis (AS) results from cholesterol accumulation in the valve between the left ventricle and aorta; this impedes the flow of blood and puts extra pressure on the heart.

Main Menu